A discovery by a scientist studying brain cancer at OMRF could be key to improving MS treatment.
Doctors at the Oklahoma Medical Research Foundation are celebrating what could become a breakthrough in brain cancer treatment.
The Oklahoma Medical Research Foundation is one step closer to beating rare forms of brain cancers.
The drug treats fast-growing, deadly brain cancers with no effective treatment.
In a new study, the OMRF compound OKN-007 is being combined with the current standard-of-care medication for glioblastoma.
Glioblastoma is an aggressive form of brain cancer with no cure, but a new OMRF discovery offers hope.